(Q43693626)

25 November 2017

Interleukin-27 enhances the production of tumour necrosis factor-α and interferon-γ by bone marrow T lymphocytes in aplastic anaemia (English)

1 reference

25 November 2017

0 references

Jianping Li

1

1 reference

25 November 2017

Qinjun Zhao

2

1 reference

25 November 2017

Wen Xing

3

1 reference

25 November 2017

Jianming Feng

4

1 reference

25 November 2017

Hao Wu

5

1 reference

25 November 2017

Huiyuan Li

6

1 reference

25 November 2017

Meili Ge

7

1 reference

25 November 2017

Kun Tian

8

1 reference

25 November 2017

Xingxin Li

9

1 reference

25 November 2017

Jianfeng Zhou

10

1 reference

25 November 2017

Bin Liu

11

1 reference

25 November 2017

Lei Zhang

12

1 reference

25 November 2017

Yizhou Zheng

13

1 reference

25 November 2017

Zhong C Han

14

1 reference

25 November 2017

language of work or name

English

0 references

publication date

21 April 2011

1 reference

British Journal of Haematology

25 November 2017

1 reference

25 November 2017

153

1 reference

25 November 2017

6

1 reference

25 November 2017

764-772

1 reference

The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27.

25 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

The biology and therapeutic potential of interleukin 27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Development of Th1-type immune responses requires the type I cytokine receptor TCCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

The stimulatory effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon gamma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

The IL-12 family of cytokines in infection, inflammation and autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Interleukin (IL)-17 promotes macrophages to produce IL-8, IL-6 and tumour necrosis factor-alpha in aplastic anaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Elevated expression of IL-12 and IL-23 in patients with aplastic anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Abnormal immunity and stem/progenitor cells in acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Guidelines for the diagnosis and management of aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

IL-12 family members: differential kinetics of their TLR4-mediated induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-derived macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Interleukin-27 directly induces differentiation in hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Understanding the pro- and anti-inflammatory properties of IL-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Immunotherapy of cancer by IL-12-based cytokine combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Antiproliferative activity of IL-27 on melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Current concepts in the pathophysiology and treatment of aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08431.X

10.1111/J.1365-2141.2010.08431.X

21 January 2018

Identifiers

DOI

1 reference

release_vmo53iyl2nbpbhfqtcqdnewrtq

25 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vmo53iyl2nbpbhfqtcqdnewrtq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference